Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

by Massimo Breccia, Michele Baccarani, Gianantonio Rosti, Francesco Cottone, Laura Cannella, François Guilhot, Marco Vignetti, Fabio Efficace
Published 2017-10-01

The EHA Research Roadmap: Malignant Myeloid Diseases

by Hartmut Döhner, Luca Malcovati, Gert J. Ossenkoppele, Andreas Hochhaus, Alessandro Maria Vannucchi, Lars Bullinger, Francisco Cervantes, Charles Craddock, Theo de Witte, Konstanze Döhner, Hervé Dombret, Pierre Fenaux, Jan Geissler, Ulrich Germing, Francois Guilhot, Claire Harrison, Eva Hellström-Lindberg, Francesco Passamonti, Jorge Sierra, Radek Skoda, Agnieszka Wierzbowska
Published 2021-09-01